Arizona - Desert Clinical Research

Mesa, Arizona 85213

0 studies enrolling now · 1 studies all time

What they study most

Non-Alcoholic Fatty Liver Disease

Studies at this site

• A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients — Completed